Sprint Bioscience

BioPartnering North America

Sprint Bioscience — Thu, 02 Feb 2012 12:45:27 +0000

Sprint Bioscience attends BioPartnering North America 2012 in Vancouver, Canada, 26-28 February.

Dr. Fredrik Rahm joins Sprint Bioscience as Principal Scientist

Sprint Bioscience — Thu, 01 Dec 2011 12:07:33 +0000

Sprint Bioscience Medicinal Chemistry team is pleased to announce that Dr. Fredrik Rahm will join us from AstraZeneca in the position as Principal Scientist starting December 1. Fredrik will strengthen Sprint Bioscience by bringing several years of fragment based drug discovery experience into our team. Welcome Fredrik!

SciBX article

Sprint Bioscience — Fri, 11 Nov 2011 14:42:34 +0000

Sprint Bioscience is featured in the article in Science Business eXchange on autophagy inhibition in cancer treatment.

SciBX 4(42); doi:10.1038/scibx.2011.1166
Published online Oct. 27 2011
Taking down autophagy – Nature

World Cancer Metabolism Summit

Sprint Bioscience — Fri, 11 Nov 2011 14:35:22 +0000

The CSO of Kancera AB will give a presentation with the titel Attacking PFKFB3 Using a Structure-Based Design Approach at the World Cancer Metabolism Summit, 1-2 of February 2012, in Washington, D.C.

World Cancer Metabolism Summit

partneringNEWS™ article

Sprint Bioscience — Fri, 11 Nov 2011 14:29:43 +0000

partneringNEWS™ published an article about Sprint Bioscience and fragment-based drug discovery.

Sprint Bioscience: Kick start for drug discovery with fragment-based screening

PSDI meeting

Sprint Bioscience — Fri, 11 Nov 2011 14:16:02 +0000

Sprint Bioscience will attend the Protein Structure Determination Industry meeting 13-15 of November 2011.

www.psdi2011.org

Sprint Bioscience expands

Sprint Bioscience — Fri, 23 Sep 2011 12:59:16 +0000

Sprint Bioscience, a fragment based drug discovery company, is growing its CRO business and speeds up the development of their in-house cancer metabolism pipe line.

In alliance with the company expansion, we are happy to welcome three new colleagues; Anne-Marie Wenthzel, Director Business Development with a strong background in life science sales and marketing , Louise Egeblad, Senior Scientist with responsibility for assay development, and Ulrika Ericsson, joining us from OctaPharma to hold the position as Principal Scientist Protein Science.

Bio-Europe Dusseldorf

Anders — Mon, 05 Sep 2011 13:27:55 +0000

Sprint Bioscience attends Partnering at BIO-Europe^® 2011 in Dusseldorf, Germany, October 31 – November 2.

Review Article

Anders — Tue, 09 Aug 2011 12:39:36 +0000

New review article in Current Opinion in Chemical Biology co-authored by Sprint Bioscience CEO, Dr. Anders Åberg

http://www.sciencedirect.com/science/article/pii/S1367593111001013

Emerging role of Autophagy in cancer

Anders — Thu, 16 Jun 2011 07:06:25 +0000

“Autophagy, the process of “self-eating” within cells, has been controversial in cancer since it was first linked to the disease in 1999. Because autophagy can either suppress or promote tumors, depending on the context. A consensus is emerging that it’s the tumor promotion role of autophagy that’s important in established tumors.”

http://jnci.oxfordjournals.org/content/early/2011/04/22/jnci.djr168.extract